Targeted resequencing of cancer-related genes with febit’s Cancer Exon Biochip

With its latest publication in the field of targeted next generation sequencing, febit sets new standards in large scale genomic studies: the HybSelect technology has been established as a highly scalable method to enrich biologically relevant exome subsets with increased sample numbers. A summary of the study on febit’s website gives an overview of the results.

Source: febit